The effect of bezlotoxumab for prevention of recurrent Clostridium difficile infection (CDI) in Japanese patients
Authors:
Open Access
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 24 (2) , 123-129
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Bezlotoxumab for Prevention of RecurrentClostridium difficileInfectionNew England Journal of Medicine, 2017
- Development and Validation of an Internationally-Standardized, High-Resolution Capillary Gel-Based Electrophoresis PCR-Ribotyping Protocol for Clostridium difficilePLOS ONE, 2015
- Epidemiology of Clostridium difficile infection in AsiaAntimicrobial Resistance & Infection Control, 2013
- Treatment with Monoclonal Antibodies againstClostridium difficileToxinsNew England Journal of Medicine, 2010
- Recurrent Clostridium DifficileGastroenterology, 2006
- Stool Form Scale as a Useful Guide to Intestinal Transit TimeScandinavian Journal of Gastroenterology, 1997